SCHEMBL886979

SCHEMBL886979

O=c1ccn(S(=O)(=O)O)c(=O)[nH]1

nearest known ligand 0.47

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
CRBN Q96SW2 4/20 0.47
DDB1 Q16531 1/20 0.42
CA1 P00915 4/20 0.36
CA2 P00918 4/20 0.36
CA4 P22748 4/20 0.36
CA9 Q16790 4/20 0.36
ALDH1A1 P00352 1/20 0.36
LMNA P02545 1/20 0.36
PKM P14618 1/20 0.35
SLC28A1 O00337 1/20 0.34
SLC28A2 O43868 1/20 0.34
SLC29A1 Q99808 1/20 0.34
SLC28A3 Q9HAS3 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8564926 0.79 CRBN (0.52) CRBNDDB1CA1CA2CA4
SCHEMBL27278428 0.71 CRBN (0.39) CRBNDDB1CA1CA2CA4
SCHEMBL7021931 0.71 CA1 (0.57) CRBNCA1CA2ALDH1A1PKM
SCHEMBL8377720 0.69
SCHEMBL24755086 0.65 CRBN (0.50) CRBNDDB1ALDH1A1LMNAPKM
SCHEMBL27581645 0.65 CRBN (0.50) CRBNDDB1ALDH1A1LMNAPKM
SCHEMBL13736277 0.64 CA1 (0.44) CA1CA2ALDH1A1LMNA
SCHEMBL5963506 0.64
SCHEMBL710129 0.64
SCHEMBL35355 0.64

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12467098-B2 Methylated markers for colorectal cancer QUEST DIAGNOSTICS INVESTMENTS LLC (US) 2025-11-11 US claimed
US-20250179583-A1 METHYLATED DNA MARKERS AND ASSAYS THEREOF FOR USE IN DETECTING COLORECTAL CANCER CEDARS-SINAI MEDICAL CENTER (US) 2025-06-05 US claimed
EP-4486917-A2 METHYLATED DNA MARKERS AND ASSAYS THEREOF FOR USE IN DETECTING COLORECTAL CANCER Cedars-Sinai Medical Center (US) 2025-01-08 EP claimed
CN-118755827-A Auxiliary detection method and kit for high-risk group of gastric cancer 青岛万物新生生物医疗科技有限公司 2024-10-11 CN claimed
CN-118703628-A DNA methylation marker auxiliary detection kit and detection method 青岛万物新生生物医疗科技有限公司 2024-09-27 CN claimed
CN-118531122-A Intestinal cell DNA methylation marker detection kit and detection method 青岛万物新生生物医疗科技有限公司 2024-08-23 CN claimed
CN-113668068-B Genome methylation library and preparation method and application thereof 广州滴纳生物科技有限公司 2024-07-19 CN claimed
WO-2023168345-A2 METHYLATED DNA MARKERS AND ASSAYS THEREOF FOR USE IN DETECTING COLORECTAL CANCER CEDARS-SINAI MEDICAL CENTER (US) 2023-09-07 WO claimed
US-20230212685-A1 METHYLATED MARKERS FOR COLORECTAL CANCER QUEST DIAGNOSTICS INVESTMENTS LLC (US) 2023-07-06 US claimed
US-11486007-B2 Methylated markers for colorectal cancer QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) 2022-11-01 US claimed
EP-3101141-A2 METHOD FOR METHYLATION ANALYSIS Epigenomics AG (DE) 2016-12-07 EP claimed
EP-2479289-B1 Method for methylation analysis EPIGENOMICS AG (DE) 2016-04-06 EP claimed
WO-2015187823-A2 METHYLATED MARKERS FOR COLORECTAL CANCER QUEST DIAGNOSTICS INVESTMENTS INCORPORATED (US) 2015-12-10 WO claimed
US-8623599-B2 Method for methylation analysis EPIGENOMICS AG (DE) 2014-01-07 US claimed
EP-2479289-A2 Method for methylation analysis Epigenomics AG (DE) 2012-07-25 EP claimed
US-20110009277-A1 METHOD FOR METHYLATION ANALYSIS NEW DAY DIAGNOSTICS LLC 2011-01-13 US claimed
EP-2152902-A2 METHOD FOR METHYLATION ANALYSIS Epigenomics AG (DE) 2010-02-17 EP claimed
US-20100021902-A1 Method for methylation-selective amplification EPIGENOMICS AG (DE) 2010-01-28 US claimed
EP-2143807-A1 Method for methylation-selective amplification Epigenomics AG (DE) 2010-01-13 EP claimed
WO-2008149237-A2 METHOD FOR METHYLATION ANALYSIS EPIGENOMICS AG (DE) 2008-12-11 WO claimed